翻訳と辞書 |
Amycolatopsis rifamycinica : ウィキペディア英語版 | Amycolatopsis rifamycinica
''Amycolatopsis rifamycinica'' is a species of Gram-positive bacteria in the ''Amycolatopsis'' genus. It produces the rifamycin antibiotics (e.g. rifamycin SV), which are used to treat mycobacterial diseases such as tuberculosis and leprosy. ''Amycolatopsis rifamycinica'' has been renamed several times. When it was first isolated from a French soil sample in 1957, it was identified as ''Streptomyces mediterranei''. In 1969, the bacterium was renamed ''Nocardia mediterranei'' because its cell wall was thought to resemble that of ''Nocardia'' species. The bacterium was renamed ''Amycolatopsis mediterranei'' in 1986 after finding that it is not susceptible to ''Nocardia'' phage and has a cell wall that lacks mycolic acid. Finally, in 2004, it was renamed ''Amycolatopsis rifamycinica'' based on 16S ribosomal RNA sequencing. == References == 〔
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Amycolatopsis rifamycinica」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|